Company intelligence / Profile preview

BelliWelli

United States

Ownership: Private
Development stage: Other

Overview

BelliWelli offers probiotic snack bars and fiber supplements formulated to support digestive health, especially for people managing IBS or following a low FODMAP diet; products are co-developed with GI doctors, are plant-based, dairy- and gluten-free, and commercially available online and in select stores.

Therapeutic areas: Gastroenterology
Modalities: Non-pharmacological therapy
Industry: Food & Nutrition

Partnerships

Partners with top gastroenterologists in product formulation

Beyond the preview

Go deeper on BelliWelli.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BelliWelli.

Explore the full profile